July 2020

MIMS Full Prescribing Update

New / Revised

Product Name

Section changed
New Accusol 35
New Azithromycin-AFT
New Carbetocin Wockhardt
New CeraVe Skin Care
New Cipla Gefitinib
New Imodium Zapid Tablets
New Isotretinoin Lupin
New Liquibar
New Liquibar CT
New Melobic
New Melotin MR
New Noumed Amoxicillin
New Noumed Atorvastatin
New Noumed Risperidone
New Ozempic
New Phentermine Juno ER
New Potassium Chloride Juno
New Rixadone Oral Solution
New Topotecan Accord
New Vital 1.5kcal
New Xiidra
New X-Opaque-HD
Reinstated Imodium Advanced Chewable Tablets
Revised Acarizax Adverse Effects (Undesirable Effects)
Revised Adenosine Juno TGA Date
Revised Aethoxysklerol Nature and Contents of Container, Pharmaceutical Form
Revised Aimovig Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Alcaine Eye Drops 0.5% TGA Date
Revised Aldomet TGA Date
Revised Alprolix Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties
Revised Alzene Nature and Contents of Container, TGA Date
Revised Amisulpride Sandoz Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Amisulpride Winthrop Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Amoxil Oral Nature and Contents of Container, Pharmaceutical Form, Special Warnings and Precautions for Use
Revised Anzatax Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Special Warnings and Precautions for Use
Revised APO-Cephalexin Capsules Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use
Revised APO-Escitalopram Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised APO-Ezetimibe Nature and Contents of Container
Revised APO-Flecainide Nature and Contents of Container, Sponsor
Revised APO-Fluvoxamine Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use
Revised APO-Meloxicam Capsules List of Excipients, Pharmacological Properties, Physicochemical Properties, Special Warnings and Precautions for Use
Revised APO-Meloxicam Tablets Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use
Revised APO-Metformin XR Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties
Revised APO-Olmesartan/HCTZ Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use
Revised APO-Telmisartan HCTZ Contraindications, Overdose, Physicochemical Properties, Special Warnings and Precautions for Use
Revised APO-Topiramate Special Warnings and Precautions for Use
Revised APO-Zolpidem Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Special Warnings and Precautions for Use
Revised Asmol CFC-free Inhaler Adverse Effects (Undesirable Effects), Pharmaceutical Form, Special Warnings and Precautions for Use
Revised AstraZeneca Pethidine Injection BP Boxed Warnings, Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Product Name change, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Atorvachol Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use, Sponsor
Revised Avil Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Axit Adverse Effects (Undesirable Effects)
Revised Azacitidine Accord TGA Date
Revised Betmiga List of Excipients, Nature and Contents of Container
Revised Blooms the Chemist Escitalopram Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Blooms the Chemist Ezetimibe Nature and Contents of Container
Revised Brimica Genuair 340/12 Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions
Revised Brufen Adverse Effects (Undesirable Effects), Overdose, Special Warnings and Precautions for Use
Revised Captopril Sandoz Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Celecoxib Apotex TGA Date
Revised Cetrotide TGA Date
Revised Charcotrace TGA Date
Revised Cilamox Sponsor
Revised Cilicaine VK Sponsor
Revised Clopidogrel GH Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container
Revised Codalgin Forte Sponsor, TGA Date
Revised Comfarol Forte Adverse Effects (Undesirable Effects), Boxed Warnings, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, New indication, Overdose, Special Warnings and Precautions for Use
Revised Coregas Medical Oxygen and Oxygen (Liquid) Presentation
Revised Cosopt Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Cosopt Preservative Free Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Crinone TGA Date
Revised Curam 125/31.25 Powder for Suspension TGA Date
Revised Curam Duo 400/57 Powder for Suspension Adverse Effects (Undesirable Effects)
Revised Curam Duo 500/125 and Curam Duo Forte 875/125 Tablets Adverse Effects (Undesirable Effects)
Revised Cyklokapron TGA Date
Revised Dalacin T Topical Lotion TGA Date
Revised Dalacin V Cream 2% TGA Date
Revised DBL Ergometrine Injection Special Warnings and Precautions for Use
Revised DBL Fentanyl Injection TGA Date
Revised DBL Flucloxacillin Sodium Powder for Injection Special Warnings and Precautions for Use
Revised DBL Pentamidine Isethionate for Injection Physicochemical Properties
Revised DBL Pethidine Hydrochloride Injection BP Boxed Warnings, Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications
Revised DBL Sodium Thiosulfate Injection TGA Date
Revised Diabex XR List of Excipients, Pharmaceutical Form, Qualitative and Quantitative Composition
Revised Diazepam Elixir TGA Date
Revised Dificid TGA Date
Revised Doxylin Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use
Revised DuoResp Spiromax Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Ebixa List of Excipients
Revised Eldepryl TGA Date
Revised Enstilar Adverse Effects (Undesirable Effects), Pharmaceutical Form, Shelf Life
Revised Entyvio Adverse Effects (Undesirable Effects), Pharmaceutical Form, Pharmacological Properties, Physicochemical Properties, Qualitative and Quantitative Composition, Special Precautions for Storage, Special Warnings and Precautions for Use
Revised Ephedrine Hydrochloride MYX TGA Date
Revised Epiramax Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Estalis Continuous Effects on Ability to Drive and Use Machines, Pharmaceutical Form, Pharmacological Properties
Revised Estalis Sequi TGA Date
Revised Estradot Effects on Ability to Drive and Use Machines, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Physicochemical Properties, Qualitative and Quantitative Composition, Special Precautions for Storage
Revised Evogam TGA Date
Revised Exelon Qualitative and Quantitative Composition
Revised Fabrazyme TGA Date
Revised Femara Physicochemical Properties
Revised Finasteride-1mg List of Excipients
Revised Fludarabine JUNO TGA Date
Revised Fluticasone Cipla Special Warnings and Precautions for Use
Revised Fosamax Plus Dose and Method of Administration
Revised Gaviscon Double Strength New Presentation of Brand already available
Revised Glycoprep Contraindications, Dosage and Administration, Interactions with Other Medicines, Precautions
Revised Go Kit Adverse Effects, Contraindications, Description, Dosage and Administration, Indications, Interactions with Other Medicines, Overdosage, Pharmacology, Precautions, Presentation, Storage
Revised Halaven TGA Date
Revised Hepatitis B Immunoglobulin-VF TGA Date
Revised Herceptin SC Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Hizentra Nature and Contents of Container
Revised Ibiamox TGA Date
Revised Imigran TGA Date
Revised Infacol Product Name change
Revised Intralipid Dose and Method of Administration, Shelf Life, Special Warnings and Precautions for Use
Revised Iomeron Nature and Contents of Container
Revised Ipol Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Incompatibilities, Pharmacological Properties, Shelf Life, Special Warnings and Precautions for Use
Revised Janumet TGA Date, TGA Date
Revised Janumet XR TGA Date, TGA Date
Revised Junalox TGA Date
Revised Keytruda Dose and Method of Administration
Revised Lanoxin TGA Date
Revised Lipiodol Ultra Fluid Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, New indication, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Liposomal Doxorubicin SUN TGA Date
Revised Locacorten-Vioform Ear Drops TGA Date
Revised Lofenoxal Effects on Ability to Drive and Use Machines, Overdose, Qualitative and Quantitative Composition
Revised Logicin Rapid Relief Nasal Spray Sponsor
Revised Logicin Sinus Tablets Adverse Effects, Contraindications, Dosage and Administration, Excipients, Indications, Interactions with Other Medicines, Overdosage, Pharmacology, Precautions, Presentation
Revised Lomotil Qualitative and Quantitative Composition
Revised Loxalate Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Lyclear Dosage and Administration, Precautions
Revised Macrodantin TGA Date
Revised Malarone Tablets (250/100), Malarone Junior Tablets (62.5/25) TGA Date
Revised Minax Fertility, Pregnancy and Lactation, Overdose, Pharmacological Properties, Special Precautions for Storage
Revised Minims Tropicamide Eye Drops Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use
Revised Minomycin Effects on Ability to Drive and Use Machines, List of Excipients, Nature and Contents of Container, Sponsor
Revised Mirtanza ODT Adverse Effects (Undesirable Effects)
Revised Mizart HCT Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Special Warnings and Precautions for Use
Revised Monurol TGA Date
Revised Movapo Pen List of Excipients, Special Precautions for Storage
Revised Mundicare Burnaid Burn Dressing Product Name change, Sponsor
Revised Mundicare Itch Relief Spray Product Name change, Sponsor
Revised Mundicare Skin Relief Cream Product Name change, Sponsor
Revised Mundicare Skin Relief Powder Product Name change, Sponsor
Revised Naloxone Juno TGA Date
Revised Neuroccord Special Warnings and Precautions for Use
Revised NortriTABS TGA Date
Revised OctreoScan Nature and Contents of Container, Physicochemical Properties
Revised Odaplix SR TGA Date
Revised Oncaspar Powder for Injection Shelf Life
Revised Ondansetron Kabi Dose and Method of Administration, Fertility, Pregnancy and Lactation
Revised Ondansetron Mylan Fertility, Pregnancy and Lactation
Revised Ondansetron Mylan ODT Fertility, Pregnancy and Lactation
Revised Ondansetron ODT GH Fertility, Pregnancy and Lactation
Revised Ondansetron ODT-DRLA Fertility, Pregnancy and Lactation
Revised Ondansetron SZ Fertility, Pregnancy and Lactation
Revised Ondansetron SZ ODT Fertility, Pregnancy and Lactation
Revised Ondansetron-DRLA Fertility, Pregnancy and Lactation
Revised Ontruzant TGA Date
Revised Orion Chloral Hydrate Mixture TGA Date
Revised Oxycodone Mylan Product Name change
Revised Palexia IR Fertility, Pregnancy and Lactation
Revised Palexia SR Fertility, Pregnancy and Lactation
Revised Panadeine Forte Boxed Warnings, Contraindications, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Paracetamol/Codeine GH 500/30 Contraindications, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Pavtide TGA Date
Revised Pemetrexed Accord TGA Date
Revised Pemetrexed APOTEX Dose and Method of Administration
Revised Pentastan DTPA Reagent Multi Dose Vials Description, Dosage and Administration, Presentation
Revised Perjeta Dose and Method of Administration, Effects on Ability to Drive and Use Machines
Revised Pfizer (Perth) Sterile Potassium Chloride Concentrate Product Name change
Revised Pharmacor Rosuvastatin TGA Date
Revised Ponstan Special Warnings and Precautions for Use
Revised Prevymis Dose and Method of Administration, Incompatibilities, Pharmaceutical Form
Revised Primacin Pharmaceutical Form
Revised Prodeine Forte Boxed Warnings, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Propecia List of Excipients
Revised ProQuad Dose and Method of Administration, Special Warnings and Precautions for Use
Revised Proscar TGA Date
Revised Prozac TGA Date
Revised Questran Lite List of Excipients, Sponsor
Revised Remicade TGA Date
Revised Revestive Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use
Revised RiaSTAP Dose and Method of Administration, Nature and Contents of Container
Revised Risperdal Consta TGA Date
Revised Risperdal, Risperdal Oral Solution Nature and Contents of Container
Revised Samsca TGA Date
Revised Sandostatin Dose and Method of Administration, Nature and Contents of Container
Revised Sandrena TGA Date
Revised Saxenda Overdose
Revised Seretide TGA Date
Revised Sigmaxin Physicochemical Properties, Shelf Life
Revised Sodium Chloride 0.9% Injection BP Nature and Contents of Container
Revised Sodium Chloride Concentrated Injections 20% and 23.4% TGA Date
Revised Somidem Adverse Effects (Undesirable Effects), New contraindication, Special Warnings and Precautions for Use
Revised Spiriva TGA Date
Revised Stelara Adverse Effects (Undesirable Effects), Dose and Method of Administration, Nature and Contents of Container, New indication, Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use
Revised Stelax Adverse Effects (Undesirable Effects), Dose and Method of Administration, Overdose, Special Warnings and Precautions for Use
Revised Strattera TGA Date
Revised Symmetrel TGA Date
Revised Tamiflu Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Pharmacological Properties
Revised Tazopip Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Telmisartan HCT GH Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Telmisartan/HCT Sandoz Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Special Warnings and Precautions for Use
Revised Temaze TGA Date
Revised Temgesic Boxed Warnings, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, New contraindication, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Tenaxil SR TGA Date
Revised Tevaripiprazole TGA Date
Revised Teveten Plus Special Warnings and Precautions for Use
Revised Tranexamic-AFT TGA Date
Revised Tremfya Adverse Effects (Undesirable Effects), Dose and Method of Administration, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use
Revised Twinrix Preservative Free List of Excipients, Qualitative and Quantitative Composition
Revised Tykerb TGA Date
Revised VAQTA TGA Date
Revised Varivax Refrigerated Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Therapeutic Indications
Revised Veletri Dose and Method of Administration
Revised Venofer TGA Date
Revised Verzenio TGA Date
Revised Vesanoid Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions
Revised Visipaque Injection List of Excipients, Pharmacological Properties, Special Precautions for Storage
Revised Vitalipid N Dose and Method of Administration, Nature and Contents of Container, Pharmaceutical Form, Shelf Life, Special Precautions for Storage
Revised Vivotif Oral Sponsor
Revised Voxam Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Physicochemical Properties, Special Warnings and Precautions for Use
Revised Water for Injections BP (Phebra) TGA Date
Revised Xarelto Contraindications, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Xifaxan 200 mg TGA Date
Revised Xifaxan 550 mg TGA Date
Revised Zavesca Pharmaceutical Form
Revised Zinforo Adverse Effects (Undesirable Effects), Pharmacological Properties
Deleted APO-Alendronate Plus D3
Deleted APO-Lercanidipine
Deleted Fosamax
Deleted Fosamax Plus D-Cal
Deleted Genlac
Deleted Gold Cross Antihistamine Elixir
Deleted Gold Cross Zinc Cream APF
Deleted Penthrox Inhaler
Deleted Psor-Asist Scalp Lotion
Deleted Terry White Chemists Atorvastatin
Deleted Thioprine
Deleted Tinasolve Tinea Cream

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Suite 302, Level 3, 53 Berry Street
North Sydney NSW 2060
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au